BARDEX® I.C. Infection Control Foley Catheters
The occurrence of urinary tract infection is 3.7 times greater in patients catheterised with a standard catheter than in patients catheterised with the BARDEX® I.C. Foley catheter with BACTI-GUARD®* silver alloy coating and BARD® hydrogel.
Recommended indwelling time not to exceed 28 days2.
Features and Specifications
|Balloon Size||Community Product Code (Standard Length)||Community Product Code (Female Length)||Hospital Product Code (Standard Length)||Hospital Product Code (Female Length)|
|BARDEX® I.C. AQUAFIL® Foley Catheter with Bacti-Guard®* Silver Alloy Coating and BARD® Hydrogel (With pre-filled syringe of sterile water)|
Specifications subject to change without notice. The Foley catheters included in the BARDEX® I.C. System contain Bacti-Guard® silver alloy coating licensed from Bactiguard AB. Bacti-Guard is a registered trademark of Bactiguard AB. Please consult product labels and inserts for any indications, contraindications, hazards, warnings, cautions and instructions for use 1. Clinical studies available on file at Bard Limited 2. Refer to manufacturers guidelines
- Reduces bacterial adherence
- Minimizes biofilm formation
- Inhibits migration of pathogens into the bladder
- Preserves the integrity of the urethral mucosa
- Clinically proven to reduce catheter-associated urinary tract infections1
LiteratureBARDEX IC BROCHURE.pdf
NTAC Briefing Pack
NHS Technology Adoption Centre (NTAC), commissioned by the Department of Health to encourage wider adoption of high impact innovative medical technologies, has published a BARDEX® I.C. Technology Briefing Pack. The pack provides comprehensive information and adoption considerations for clinical teams and NHS organisations and a summary of the costing information supplied by Bard to the Department of Health’s Innovative Technology Adoption Procurement Programme (iTAPP). The packs are available to NHS staff and can be downloaded by registering on the NTAC web-site: www.ntac.nhs.uk/Login.aspx?Type=AREA